98 related articles for article (PubMed ID: 7299672)
1. Interaction of povidone with aromatic compounds II: Evaluation of ionic strength, buffer concentration, temperature, and pH by factorial analysis.
Plaizier-Vercammen JA; De Nève RE
J Pharm Sci; 1981 Nov; 70(11):1252-6. PubMed ID: 7299672
[TBL] [Abstract][Full Text] [Related]
2. Interaction of povidone with aromatic compounds I: Evaluation of complex formation by factorial analysis.
Plaizier-Vercammen JA; De Nève RE
J Pharm Sci; 1980 Dec; 69(12):1403-8. PubMed ID: 7463325
[TBL] [Abstract][Full Text] [Related]
3. Interaction of povidone with aromatic compounds III: Thermodynamics of the binding equilibria and interaction forces in buffer solutions at varying pH values and varying dielectric constant.
Plaizier-Vercammen JA; De Nève RE
J Pharm Sci; 1982 May; 71(5):552-6. PubMed ID: 7097503
[TBL] [Abstract][Full Text] [Related]
4. Interaction of povidone with aromatic compounds IV: effects of macromolecule molecular weight, solvent dielectric constant, and ligand solubility on complex formation.
Plaizier-Vercammen JA
J Pharm Sci; 1983 Sep; 72(9):1042-4. PubMed ID: 6631691
[TBL] [Abstract][Full Text] [Related]
5. Interaction of povidone with aromatic compounds. VI: Use of partition coefficients (log Kd) to correlate with log P values and apparent Kd values to express the binding as a function of pH and pKa.
Plaizier-Vercammen JA
J Pharm Sci; 1987 Oct; 76(10):817-20. PubMed ID: 3430347
[TBL] [Abstract][Full Text] [Related]
6. Buffer solutions in drug formulation and processing: How pK
Samuelsen L; Holm R; Lathuile A; Schönbeck C
Int J Pharm; 2019 Apr; 560():357-364. PubMed ID: 30797864
[TBL] [Abstract][Full Text] [Related]
7. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
[TBL] [Abstract][Full Text] [Related]
8. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
[TBL] [Abstract][Full Text] [Related]
9. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
Hamed R; AlJanabi R; Sunoqrot S; Abbas A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
[TBL] [Abstract][Full Text] [Related]
10. Interaction between drugs and non-ionic macromolecules. II. Influence of buffer substances and ionic strength on complex formation. Influence of buffer and complexing compounds on the rheological properties of PVP.
Eide GJ; Speiser P
Acta Pharm Suec; 1967 Jun; 4(3):201-10. PubMed ID: 5594409
[No Abstract] [Full Text] [Related]
11. Effect of pH, ionic strength and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions. Part 1: Lipid hydrolysis.
Zhang JA; Pawelchak J
Eur J Pharm Biopharm; 2000 Nov; 50(3):357-64. PubMed ID: 11072192
[TBL] [Abstract][Full Text] [Related]
12. Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
Pramar Y; Gupta VD
J Pharm Sci; 1991 Jun; 80(6):551-3. PubMed ID: 1941547
[TBL] [Abstract][Full Text] [Related]
13. Theory and computer programs for calculating solution pH, buffer formula, and buffer capacity for multiple component system at a given ionic strength and temperature.
Okamoto H; Mori K; Ohtsuka K; Ohuchi H; Ishii H
Pharm Res; 1997 Mar; 14(3):299-302. PubMed ID: 9098870
[TBL] [Abstract][Full Text] [Related]
14. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies on the interaction of proteins with a polydimethylsiloxane elastomer. I. Monolayer protein capture capacity (PCC) as a function of protein pl, buffer pH and buffer ionic strength.
Butler JE; Lü EP; Navarro P; Christiansen B
J Mol Recognit; 1997; 10(1):36-51. PubMed ID: 9179778
[TBL] [Abstract][Full Text] [Related]
16. Solvolysis of a substituted imidazoline, mazindol.
Maulding HV; Turi P; Grossman D; Nazareno JP
J Pharm Sci; 1975 Nov; 64(11):1833-8. PubMed ID: 482
[TBL] [Abstract][Full Text] [Related]
17. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
Parasrampuria J; Gupta VD
J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
[TBL] [Abstract][Full Text] [Related]
18. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
Low JE; Borch RF; Sladek NE
Cancer Res; 1983 Dec; 43(12 Pt 1):5815-20. PubMed ID: 6640533
[TBL] [Abstract][Full Text] [Related]
19. Buffer formulation affects the interaction between lysozyme and polymeric nanoparticles.
Lundqvist M; Cabaleiro-Lago C
J Colloid Interface Sci; 2017 Oct; 504():78-85. PubMed ID: 28527828
[TBL] [Abstract][Full Text] [Related]
20. Effect of ionic strength and ionic composition of assay buffers on the interaction of thyroxine with plasma proteins.
Sutherland RL; Brandon MR; Simpson-Morgan MW
J Endocrinol; 1975 Sep; 66(3):319-27. PubMed ID: 447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
